http://www.fermion.fi/who-we-are/news/fermion-begins-renovation-to-expand-api-manufacturing-capacity-at-hanko-site/2025-08-07T12:48:59+03:00weekly0.7http://www.fermion.fi/who-we-are/news/q1therapeutics-fda-approval-cosela/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/Orion-cmo-award-expertise/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/brochures-and-articles/your-innovative-api-from-development-to-market-part-1-the-proposal/2021-06-23T11:46:29+03:00weekly0.7http://www.fermion.fi/who-we-are/brochures-and-articles/project-management-and-the-fermion-experience/2025-06-04T08:59:59+03:00weekly0.7http://www.fermion.fi/who-we-are/brochures-and-articles/do-it-once-do-it-right-at-fermions-rd/2021-06-28T15:31:00+03:00weekly0.7http://www.fermion.fi/who-we-are/brochures-and-articles/how-automation-makes-for-quicker-cheaper-and-safer-api-production/2021-06-28T15:30:48+03:00weekly0.7http://www.fermion.fi/who-we-are/brochures-and-articles/high-quality-product-to-market/2021-06-28T15:30:33+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/oulu-site/2025-09-26T09:36:38+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/hanko-site/2025-09-09T15:50:58+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/orion-turku-site/2021-06-23T12:26:26+03:00weekly0.7http://www.fermion.fi/cdmo-api/technical-capabilities-of-rd/kilo-facility/2021-06-30T13:52:58+03:00weekly0.7http://www.fermion.fi/cdmo-api/technical-capabilities-of-rd/pilot-plant/2021-06-29T13:25:07+03:00weekly0.7http://www.fermion.fi/cdmo-api/technical-capabilities-of-rd/rd-laboratory/2024-04-17T15:12:32+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/orions-salo-site/2021-06-03T15:51:47+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/orions-espoo-site/2021-06-23T12:26:48+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/semi-solids-and-liquids/hormonal-semi-solids-and-liquids/2021-06-24T07:55:33+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/semi-solids-and-liquids/non-hormonal-semisolids-and-liquids/2021-06-24T07:56:26+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/semi-solids-and-liquids/quality/2021-06-24T07:56:47+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/oral-solids/quality/2021-06-24T07:58:58+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/oral-solids/cytotoxic-tablets/2021-06-22T10:52:18+03:00weekly0.7http://www.fermion.fi/cmo-drug-product/oral-solids/non-cytotoxic-oral-solids/2021-06-24T07:58:27+03:00weekly0.7http://www.fermion.fi/who-we-are/news/orion-uses-waste-ethanol-to-reduce-the-nitrogen-load-in-the-baltic-sea/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-increases-manufacturing-capacity-for-apis-at-its-hanko-site-with-new-module/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/solar-energy-for-fermions-hanko-plant/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-has-received-ceps-for-benserazide-hcl-and-entacapone/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/seasons-greetings-from-fermion-president-arto-toivonen/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/how-to-succeed-in-technology-transfers-for-hormonal-gels--4-critical-factors/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/orion-as-a-long-term-partner-for-production-of-hormonal-gels--customer-view/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-scales-up-its-oeb5-micronization-capabilities/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/green-chemistry-strengthens-orions-environmental-responsibility/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-has-received-fluticasone-propionate-cep/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/contact/contact-form/thank-you/2021-09-03T12:26:19+03:00weekly0.7http://www.fermion.fi/who-we-are/facilities/testpage/2021-08-26T09:28:12+03:00weekly0.7http://www.fermion.fi/who-we-are/news/hanko-unit-4-special-synthesis-module-7-investment/2024-03-12T09:54:55+02:00weekly0.7http://www.fermion.fi/who-we-are/news/new-micronization-equipment-at-fermion-oulu-plant/2025-04-23T13:59:01+03:00weekly0.7http://www.fermion.fi/who-we-are/news/crystallization-as-a-core-competence-in-api-manufacturing/2025-06-17T09:32:18+03:00weekly0.7http://www.fermion.fi/who-we-are/news/green-chemistry/2024-08-20T09:10:01+03:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-has-completed-first-investment-for-new-manufacturing-capacity-for-apis-at-its-hanko-site/2024-03-12T10:08:24+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion-invests-in-flow-chemistry-capability/2025-01-02T15:45:54+02:00weekly0.7http://www.fermion.fi/who-we-are/news/fermion---leader-in-sustainable-api-manufacturing/2024-10-29T15:52:40+02:00weekly0.7http://www.fermion.fi/contact/contact-form/2022-08-02T09:20:20+03:00weekly0.8http://www.fermion.fi/who-we-are/sustainability/2021-07-02T11:53:59+03:00weekly0.8http://www.fermion.fi/cmo-drug-product/semi-solids-and-liquids/2021-06-23T16:22:32+03:00weekly0.8http://www.fermion.fi/cmo-drug-product/oral-solids/2021-06-29T13:35:59+03:00weekly0.8http://www.fermion.fi/cmo-drug-product/packaging/2021-06-29T13:36:31+03:00weekly0.8http://www.fermion.fi/cmo-drug-product/technology-transfer-services/2021-06-24T08:00:53+03:00weekly0.8http://www.fermion.fi/cdmo-api/development-services/2021-06-29T13:24:15+03:00weekly0.8http://www.fermion.fi/cdmo-api/technical-capabilities-of-rd/2024-04-17T13:25:57+03:00weekly0.8http://www.fermion.fi/cdmo-api/commercial-manufacturing/2024-05-03T16:38:39+03:00weekly0.8http://www.fermion.fi/cdmo-api/rfq-and-project-management/2021-07-02T11:50:00+03:00weekly0.8http://www.fermion.fi/who-we-are/facilities/2021-07-02T11:53:24+03:00weekly0.8http://www.fermion.fi/who-we-are/news/2024-03-12T09:54:55+02:00weekly0.8http://www.fermion.fi/who-we-are/quality-management/2025-11-19T09:40:36+02:00weekly0.8http://www.fermion.fi/generic-api/standard-packing-sizes/2026-01-09T12:06:47+02:00weekly0.8http://www.fermion.fi/generic-api/material-safety-data-sheets/2025-05-20T13:47:34+03:00weekly0.8http://www.fermion.fi/generic-api/intermediate-list/2022-02-10T14:24:37+02:00weekly0.8http://www.fermion.fi/generic-api/api-list/2025-10-21T15:36:10+03:00weekly0.8http://www.fermion.fi/cdmo-api/bayers-experiences-in-development-of-api-process-for-darolutamide-with-fermion/2021-06-24T08:03:26+03:00weekly0.8http://www.fermion.fi/who-we-are/fermions-history/2021-07-02T11:44:54+03:00weekly0.8http://www.fermion.fi/who-we-are/management/2025-01-03T15:36:21+02:00weekly0.8http://www.fermion.fi/who-we-are/brochures-and-articles/2025-10-21T15:30:51+03:00weekly0.8http://www.fermion.fi/privacy-policy/2021-06-22T11:51:31+03:00weekly0.9http://www.fermion.fi/not-found-404/2022-09-26T18:08:06+03:00weekly0.9http://www.fermion.fi/error-500/2022-09-26T18:08:15+03:00weekly0.9http://www.fermion.fi/cookie-policy/2021-06-22T11:51:11+03:00weekly0.9http://www.fermion.fi/cdmo-api/2021-06-29T13:23:25+03:00weekly0.9http://www.fermion.fi/cmo-drug-product/2021-07-02T11:50:37+03:00weekly0.9http://www.fermion.fi/who-we-are/2021-07-02T11:43:48+03:00weekly0.9http://www.fermion.fi/search/2021-05-28T10:37:02+03:00weekly0.9http://www.fermion.fi/contact/2022-08-01T14:04:37+03:00weekly0.9http://www.fermion.fi/generic-api/2021-07-02T11:45:39+03:00weekly0.9http://www.fermion.fi/contact-form/2021-08-24T14:31:56+03:00weekly0.9http://www.fermion.fi/2026-02-23T10:07:25+02:00weekly1